Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $645K | ﹤0.01% |
16,300
-28,100
| -63% | -$1.22M |
|
2727
Yatra Online
YTRA
$54.1M
| $644K | ﹤0.01% |
511,336
-17,900
| -3% | -$26K |
|
|
LUNA
2728
DELISTED
Luna Innovations Incorporated
LUNA
| $643K | ﹤0.01% |
297,600
+124,300
| +72% | +$220K |
|
2729
IRIDEX
IRIX
$14.3M
| $640K | ﹤0.01% |
381,160
-16,200
| -4% | -$26.7K |
|
2730
Cerus
CERS
$441M
| $640K | ﹤0.01% |
415,609
-142,891
| -26% | -$246K |
|
2731
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.87B
| $640K | ﹤0.01% |
17,100
-11,300
| -40% | -$431K |
|
2732
National Bankshares
NKSH
$262M
| $639K | ﹤0.01% |
22,270
| – | – |
|
2733
Exagen
XGN
$156M
| $638K | ﹤0.01% |
155,536
-20,064
| -11% | -$72.3K |
|
2734
InnovAge Holding
INNV
$1.47B
| $637K | ﹤0.01% |
162,000
+20,500
| +14% | +$106K |
|
2735
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.29B
| $636K | ﹤0.01% |
+6,000
| New | +$664K |
|
2736
Vanguard Total World Stock ETF
VT
$79.4B
| $634K | ﹤0.01% |
5,400
-7,300
| -57% | -$876K |
|
2737
Vanguard Health Care ETF
VHT
$18.2B
| $634K | ﹤0.01% |
2,500
-800
| -24% | -$216K |
|
2738
Arq
ARQ
$88.9M
| $633K | ﹤0.01% |
+83,600
| New | +$550K |
|
2739
Zevia
ZVIA
$124M
| $632K | ﹤0.01% |
150,726
+51,300
| +52% | +$105K |
|
2740
RH
RH
$3.56B
| $630K | ﹤0.01% |
+1,600
| New | +$569K |
|
2741
ECARX Holdings
ECX
$432M
| $630K | ﹤0.01% |
+298,427
| New | +$550K |
|
2742
First Mid Bancshares
FMBH
$1.4B
| $630K | ﹤0.01% |
17,100
+1,900
| +13% | +$75.6K |
|
2743
Heritage Global
HGBL
$35.4M
| $629K | ﹤0.01% |
339,817
+9,222
| +3% | +$15.6K |
|
2744
Quanterix
QTRX
$175M
| $628K | ﹤0.01% |
59,100
-73,005
| -55% | -$888K |
|
2745
First Trust Managed Municipal ETF
FMB
$2.06B
| $627K | ﹤0.01% |
12,300
-107,364
| -90% | -$5.52M |
|
2746
iShares Core MSCI Europe ETF
IEUR
$9.09B
| $626K | ﹤0.01% |
11,600
-7,300
| -39% | -$416K |
|
2747
Fate Therapeutics
FATE
$300M
| $625K | ﹤0.01% |
378,619
+16,000
| +4% | +$40.3K |
|
|
VIGL
2748
DELISTED
Vigil Neuroscience
VIGL
| $624K | ﹤0.01% |
367,300
+321,300
| +698% | +$949K |
|
|
ACHL
2749
DELISTED
Achilles Therapeutics
ACHL
| $624K | ﹤0.01% |
547,233
-90,900
| -14% | -$93.7K |
|
|
BMTX
2750
DELISTED
BM Technologies, Inc.
BMTX
| $621K | ﹤0.01% |
127,000
+53,297
| +72% | +$232K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.